BioAdvance News

Niiki Pharma to Present Preclinical Results, Start Testing Cancer Drug

By WebmasterMarch 28, 2012November 1st, 2024No Comments

Niiki Pharma to Present Preclinical Results, Start Testing Cancer Drug
Read more here

Previous PostNiiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent
Next PostQR Pharma Has a Gut Feeling about Parkinson's